Latest Production News

Aspire Mining Limited has refined its Ovoot Coking Coal Project development plans to reduce upfront capital expenditure, progressing towards mining commencement in Q4 2025 amid positive market feedback and advancing infrastructure contracts.

Aumake Limited reported a remarkable 213% surge in quarterly cash receipts, driven by exclusive distribution agreements and strategic cost reductions, setting the stage for profitability in FY26.

Atomos Limited faced a challenging Q4 FY25 with US tariff disruptions but rebounded strongly in June, launching new products and appointing Peter Barber as CEO to drive future growth.

Oakridge International reported robust revenue growth and expanded its partner network in Q4 2025, underpinning a promising outlook in healthcare technology. The company also advanced product innovation aligned with new industry standards.

Gathid Ltd reported a robust 14% quarterly increase in Annual Recurring Revenue to $1.936 million, driven by new customer wins and expansions, even as a legal dispute over its physical security business sale remains unresolved.

Optiscan Imaging Ltd has launched its first in-human breast cancer study and unveiled a new veterinary imaging device, while securing a key US collaboration to support FDA submissions.

Chilwa Minerals has significantly boosted its Mineral Resource Estimate by 85% to 110 million tonnes, with a majority now in the Indicated category, underpinning ongoing feasibility studies and rare earth exploration in Malawi.

Botanix Pharmaceuticals confirms material sales and prescription growth data, explaining the timing of its ASX disclosures amid share price fluctuations.

PointsBet Holdings has dismissed Betr Entertainment's increased scrip takeover offer, reaffirming its support for MIXI's competing bid amid ongoing regulatory scrutiny.

American West Metals reports promising drilling results at its Storm Copper Project and advances critical minerals exploration in Utah, backed by strategic funding and offtake agreements.

High Peak Royalties Limited reported stable royalty receipts of A$345,240 for the June 2025 quarter, maintaining cash flow while advancing monitoring of key gas and geothermal assets across Australia and the US.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.